Clofazimine: History and Perspectives

by G. N. Mozhokina, A. G. Samoylova
Published 2021-06-01

Nephrotoxic characteristics of anti-tuberculosis drugs

by G. N. Mozhokina, A. G. Samoylova, Z. A. Zangieva
Published 2019-11-01

The problem of neurotoxicity of drugs in the treatment of tuberculosis patients

by G. N. Mozhokina, A. G. Samoylova, I. A. Vasilyeva
Published 2020-11-01

Biotransformation enzymes for xenobiotics and personalization of treatment regimens for tuberculosis patients

by G. N. Mozhokina, A. V. Kazakov, N. A. Elistratova, S. A. Popov
Published 2016-04-01

INVESTIGATION OF CO-TRIMOXAZOLE EFFICIENCY USING THE EXPERIMENTAL TUBERCULOSIS MODEL IN MICE CAUSED BY TUBERCULOUS MYCOBACTERIA WITH EXTENSIVE DRUG RESISTANCE

by S. A. Popov, G. N. Mozhokina, S. A. Kosenkov, N. A. Elistratova, T. P. Sabgayda
Published 2017-02-01

Parameters of hepatotoxic reactions caused by the combination of first line anti-tuberculosis drugs in rats with different acetylation phenotypes

by G. N. Mozhokina, А. V. Kazakov, Yu. R. Zyuzya, L. Yu. Petrova
Published 2020-08-01

EXPERIMENTAL RATIONALE FOR THE USE OF ROPRENE TO PREVENT ISONIAZID-INDUCED LIVER DAMAGES

by G. N. Mozhokina, N. A. Elistratova, L. P. Mikhailova, O. V. Makarova, V. S. Sultanov, V. B. Trusov
Published 2014-07-01

FREQUENCY OF HEPATOTOXIC REACTIONS IN NEW PULMONARY TUBERCULOSIS PATIENTS WITH GENETIC POLYMORPHISM OF GENE-ENZYMES RESPONSIBLE FOR XENOBIOTIC BIOTRANSFORMATION

by A. V. Kazakov, G. N. Mozhokina, N. I. Klevno, S. V. Smerdin, A. D. Pakhlavonova, P. V. Senchikhin, Kh. B. Dadasheva
Published 2019-05-01